Agency Information Collection Activities; Renewal of an Approved Information Collection: Non-Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5872

Issuing agencies

Abstract

In accordance with the Paperwork Reduction Act of 1995, FMCSA announces its plan to submit the Information Collection Request (ICR) described below to the Office of Management and Budget (OMB) for review and approval and invites public comment. FMCSA requests approval to renew an ICR titled, "Non-Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5872." This information collection (IC) is voluntary and may be utilized by certified medical examiners (MEs) responsible for issuing Medical Examiner's Certificates (MEC), Form MCSA-5876, to individuals diagnosed with non-insulin-treated diabetes mellitus who operate commercial motor vehicles (CMVs). MEs choosing to use this IC will do so in an effort to communicate with treating healthcare providers who manage the diabetes care of individuals diagnosed with non-insulin-treated diabetes mellitus who operate CMVs. The information obtained by MEs will assist them in determining if an individual diagnosed with non-insulin-treated diabetes mellitus meets FMCSA's physical qualification standards.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 163 (Tuesday, August 25, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 163 (Tuesday, August 25, 2026)]
[Notices]
[Pages 54912-54914]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-17340]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2026-1783]


Agency Information Collection Activities; Renewal of an Approved 
Information Collection: Non-Insulin-Treated Diabetes Mellitus 
Assessment Form, MCSA-5872

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department 
of Transportation (DOT).

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FMCSA 
announces its plan to submit the Information Collection Request (ICR) 
described below to the Office of Management and Budget (OMB) for review 
and approval and invites public comment. FMCSA requests approval to 
renew an ICR titled, ``Non-Insulin-Treated Diabetes Mellitus Assessment 
Form, MCSA-5872.'' This information collection (IC) is voluntary and 
may be utilized by certified medical examiners (MEs) responsible for 
issuing Medical Examiner's Certificates (MEC), Form MCSA-5876, to 
individuals diagnosed with non-insulin-treated diabetes mellitus who 
operate commercial motor vehicles (CMVs). MEs choosing to use this IC 
will do so in an effort to communicate with treating healthcare 
providers who manage the diabetes care of individuals diagnosed with 
non-insulin-treated diabetes mellitus who operate CMVs. The information 
obtained by MEs will assist them in determining if an individual 
diagnosed with non-insulin-treated diabetes mellitus meets FMCSA's 
physical qualification standards.

DATES: Comments on this notice must be received on or before October 
26, 2026.

ADDRESSES: You may submit comments identified by Docket Number FMCSA-
2026-1783 using any of the following methods:
    <bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>. 
Follow the online instructions for submitting comments.
    <bullet> Mail: Dockets Operations; U.S. Department of 
Transportation, 1200 New Jersey Avenue SE, W58-213, West Building, 
Washington, DC 20590-0001.
    <bullet> Hand Delivery or Courier: Dockets Operations, U.S. 
Department of Transportation, 1200 New Jersey Avenue SE, W58-213, 
Washington, DC 20590-0001 between 9 a.m. and 5 p.m. ET, Monday through 
Friday, except Federal holidays.
    <bullet> Fax: (202) 493-2251.
    To avoid duplication, please use only one of these four methods. 
See the ``Public Participation and Request for Comments'' portion of 
the SUPPLEMENTARY INFORMATION section for instructions on submitting 
comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Medical Programs Division, DOT, FMCSA, 1200 New Jersey Avenue SE, 
Washington, DC 20590-0001; (202) 366-4001; <a href="/cdn-cgi/l/email-protection#33555e5040525e56575a50525f73575c471d545c45"><span class="__cf_email__" data-cfemail="83e5eee0f0e2eee6e7eae0e2efc3e7ecf7ade4ecf5">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION:

Instructions

    All submissions must include the Agency name and docket number. For 
detailed instructions on submitting comments, see the Public 
Participation heading below. Note that all comments received will be 
posted without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any 
personal information provided. Please see the Privacy Act heading 
below.

Public Participation and Request for Comments

    If you submit a comment, please include the docket number for this 
notice (FMCSA-2026-1783), indicate the specific section of this 
document to which your comment applies, and provide a reason for each 
suggestion or recommendation. You may submit your comments and material 
online or by fax, mail, or hand delivery, but please use only one of 
these means. FMCSA recommends that you include your name and a mailing 
address, an email address, or a phone number in the body of your 
document so FMCSA can contact you if there are questions regarding your 
submission.
    To submit your comment online, go to <a href="https://www.regulations.gov/docket/FMCSA-2026-1783/document">https://www.regulations.gov/docket/FMCSA-2026-1783/document</a>, click on this notice, click 
``Comment,'' and type your comment into the text box on the following 
screen.
    If you submit your comments by mail or hand delivery, submit them 
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for 
copying and electronic filing.
    FMCSA will consider all comments and material received during the 
comment period.

Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the 
public to better inform its regulatory process. DOT posts these 
comments, including any personal information the commenter provides, to 
<a href="http://www.regulations.gov">www.regulations.gov</a> as described in the system of records notice DOT/
ALL 14 (Federal Docket Management System (FDMS)), which can be reviewed 
at <a href="https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices">https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices</a>. The comments are posted without edits and are 
searchable by the name of the submitter.

Background

    The primary mission of FMCSA is to reduce crashes, injuries, and 
fatalities involving CMVs (large trucks and buses). The Secretary of 
Transportation has delegated responsibility to FMCSA under 49 U.S.C. 
31136 and 31502 to prescribe regulations that ensure CMVs are operated 
safely. As part of this mission, the Agency's Medical Programs Division 
works to ensure that individuals who operate CMVs engaged in interstate 
commerce are physically qualified and able to safely perform their 
work. CMVs characteristically pose a threat to highway safety if not 
operated properly by qualified individuals. CMVs are longer, heavier, 
and more difficult to maneuver than automobiles. Not only does it take 
a skilled driver to operate them safely, but it also takes a physically 
and mentally fit driver to do so as well. Information used to determine 
and certify driver medical fitness helps to promote and maintain safety 
on our nation's

[[Page 54913]]

highways. FMCSA is the Federal government agency authorized to request 
the collection of this information. FMCSA is required by statute to 
establish standards for the physical qualifications of drivers who 
operate CMVs in interstate commerce for non-excepted industries (49 
U.S.C. 31136(a)(3) and 31502(b)). The regulations applicable to this 
collection are outlined in the Federal Motor Carrier Safety Regulations 
(FMCSRs) at 49 CFR part 391, subpart E. The FMCSRs in 49 CFR 391.41(b) 
set forth the physical qualification standards that most individuals 
operating CMVs in interstate transportation who are subject to part 391 
must meet. The FMCSRs covering the performance of the CMV physical 
qualification examination of individuals who operate in interstate 
commerce by an ME and the related record-keeping requirements are found 
at 49 CFR 391.43. The results of the examination must be recorded in 
accordance with the requirements set forth in that section; they 
include preparing and maintaining a Medical Examination Report Form, 
MCSA-5875, and, if the individual is physically qualified, issuing an 
MEC.
    The FMCSRs in Sec.  391.41(b)(1) through (13) generally include the 
physical qualification standards required for the medical certification 
of individuals who operate a CMV in interstate commerce. The physical 
qualification standards in Sec.  391.46 address the physical 
qualification requirements for medical certification of individuals who 
are diagnosed with diabetes mellitus and are treated with insulin. 
However, the FMCSRs do not specifically address individuals who are 
diagnosed with diabetes mellitus and are treated with non-insulin 
therapy. The type of diabetes mellitus that is not treated with insulin 
(commonly known as Type 2 diabetes) is recognized as a health concern 
for the general public. Non-insulin-treated diabetes mellitus that is 
not properly managed and controlled may result in diabetes 
complications, target organ damage, and in the individual's physical 
condition being inadequate to enable the driver to operate a CMV 
safely. The physical qualification standards in the FMCSRs broadly 
address some of the conditions and symptoms that may be attributable to 
complications from non-insulin-treated diabetes mellitus. Examples 
include the loss of limb and limb impairment standard (Sec.  
391.41(b)(1) and (2)), the cardiovascular standard (Sec.  
391.41(b)(4)), the rheumatic, arthritic, orthopedic, muscular, 
neuromuscular, or vascular standard (Sec.  391.41(b)(7)), and the loss 
of consciousness standard (Sec.  391.41(b)(8)). In performing a 
thorough assessment and evaluation of an individual diagnosed with non-
insulin-treated diabetes mellitus, the ME may need to consult with the 
individual's treating healthcare provider who manages the individual's 
diabetes. The ME may find this helpful in determining whether the 
individual has any medical conditions or symptoms, such as frequent 
episodes of severe hypoglycemia, that may prevent the individual from 
meeting the physical qualification standards and receiving an MEC. This 
IC would assist the ME in collecting the appropriate information from 
the treating healthcare provider via the Non-Insulin-Treated Diabetes 
Mellitus Assessment Form, MCSA-5872, in a standardized manner and would 
assist the ME in making an informed and sound physical qualification 
determination.
    In May 2021, FMCSA's Medical Review Board (MRB) deliberated on the 
topic and contents of the Non-Insulin-Treated Diabetes Mellitus 
Assessment Form, MCSA-5872 (Task 21-2). FMCSA directed the MRB to 
review and comment on whether the information on the proposed Non-
Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5872, provides 
sufficient information concerning the treatment, management, and 
control of an individual's non-insulin-treated diabetes mellitus 
condition to assist a ME in making an appropriate physical 
qualification determination. The Agency also requested that the MRB 
identify any areas of ambiguity as well as additional information that 
FMCSA should include on the form. Based on the review of the Non-
Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5872, the MRB 
made some recommendations to improve the clarity and quality of 
information on the Non-Insulin-Treated Diabetes Mellitus Assessment 
Form, MCSA-5872 that is provided from the individual's treating 
healthcare provider to the ME.
    There is no required collection frequency for the Non-Insulin-
Treated Diabetes Mellitus Assessment Form, MCSA-5872, because the use 
of this IC is voluntary and at the discretion of the ME. The ME may use 
the Non-Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-5872, 
to facilitate communication with the treating healthcare provider 
responsible for managing the individual's non-insulin-treated diabetes 
mellitus diabetes care, and to assist the ME in determining if the 
individual meets the physical qualification standards in Sec.  
391.41(b)(1) through (13).
    The Non-Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-
5872, is available as a fillable pdf and may be downloaded from the 
FMCSA website. Treating healthcare providers can fax or scan and email 
the report to the ME. Consistent with OMB's commitment to minimizing 
respondents' recordkeeping and paperwork burdens and the increased use 
of secure electronic modes of communication, the Agency anticipates 
that approximately 50 percent of the Non-Insulin-Treated Diabetes 
Mellitus Assessment Forms, MCSA-5872, will be transmitted 
electronically.
    The information collected on the Non-Insulin-Treated Diabetes 
Mellitus Assessment Form, MCSA-5872, will be used by the ME who 
requests completion of the form and will not be available to the 
public. The Non-Insulin-Treated Diabetes Mellitus Assessment Form, 
MCSA-5872, will become a part of the individual's physical 
qualification examination records that are maintained and retained by 
the ME for a period of at least 3 years from the date of the 
examination.
    Title: Non-Insulin-Treated Diabetes Mellitus Assessment Form, MCSA-
5872.
    OMB Control Number: 2126-0081.
    Type of Request: Renewal of a currently approved ICR.
    Respondents: Treating healthcare providers of individuals who are 
diagnosed with non-insulin-treated diabetes mellitus who operate CMVs.
    Estimated Number of Respondents: 1,011,520.
    Estimated Time per Response: 8 minutes.
    Expiration Date: January 31, 2027.
    Frequency of Response: Other (Voluntary use at the medical 
discretion of the ME).
    Estimated Total Annual Burden: 27,913 hours.
    Public Comments Invited: You are asked to comment on any aspect of 
this information collection, including: (1) whether the proposed 
collection is necessary for the performance of FMCSA's functions; (2) 
the accuracy of the estimated burden; (3) ways for FMCSA to enhance the 
quality, usefulness, and clarity of the collected information; and (4) 
ways that the burden could be minimized without reducing the quality of 
the collected information. The Agency will summarize or include your 
comments in the request for OMB's clearance of this ICR.


[[Page 54914]]


    Issued under the authority of 49 CFR 1.87.
Nicole S. Michel,
Acting Associate Administrator, Office of Research and Registration.
[FR Doc. 2026-17340 Filed 8-24-26; 8:45 am]
BILLING CODE 4910-EX-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>